EQT Life Sciences (LSP)

General contacts
Investor type

PE / VC

Founded

1987

AUM

$2 690 000 M

Location

Amsterdam, North Holland, Netherlands

Investment Ticket

$10-50 m

Investment Stage

Late Stage (Series C+) Series B Seed Pre-seed Series A

Region of investment

Europe North America
Investor profile last updated: 26 September, 2026

Profile

EQT Life Sciences is a prominent life sciences investor based in Europe. The firm has a team of experienced investment professionals with backgrounds in medicine, science, and industry, focusing on innovative companies that aim to improve patient outcomes. EQT Life Sciences differentiates itself by not only providing capital but also offering strategic, clinical, operational, financial, and commercial support to its portfolio companies.

The firm invests in various sectors within life sciences, including therapeutics, medical devices, diagnostics, and healthtech. Their investment range is between 10-60 million EUR, and they target companies at all stages of development. EQT Life Sciences has raised approximately 3.5 billion EUR across 12 funds, demonstrating a strong commitment to backing innovative solutions that address unmet medical needs globally.

Notable investments include Amolyt Pharma - rare endocrine disorders, Neuravi - stroke treatment innovation, New Amsterdam Pharma - novel therapeutics, Onera Health - health monitoring solutions, and PanTera - advanced healthcare technologies. These companies reflect EQT Life Sciences' dedication to transforming scientific innovation into impactful healthcare solutions.

Industry

Life Sciences MedTech Medical Devices Digital Biotechnology HealthTech CleanTech Energy Software SaaS Robotics Healthcare Services Foodtech Food and Beverage Industrial Technology Other

EQT Life Sciences (LSP) Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
LSP Health Economics Fund II
Fund of funds
Healthcare Services
Industrial
Technology
Life Sciences
Seed
Series A
Series B
North America
Europe
$5-10 m
$280 M
January 2017
LSP Medical Technology II Fund
Fund of funds
Healthcare Services
Industrial
Technology
Life Sciences
Seed
Series A
Series B
North America
Europe
$5-10 m
$330 M
December 2017
LSP 6
Venture Capital (VC)
Healthcare Services
Industrial
Technology
Life Sciences
Seed
Series A
Series B
North America
Europe
$5-10 m
$570 M
March 2020
LSP Dementia Fund
Venture Capital (VC)
Healthcare Services
Industrial
Technology
Life Sciences
Pre-seed
Seed
North America
Europe
$5-10 m
$280 M
March 2023
Life Sciences Partners VII
Private Equity (PE)
Venture Capital (VC)
HealthTech
Energy
Life Sciences
MedTech
Software
Robotics
Other
Medical Devices
Healthcare Services
Foodtech
Food and Beverage
Digital
Biotechnology
Series A
Seed
Series B
Late Stage (Series C+)
North America
Europe
$50-100 m
$1130 M
January 2021

Contacts

Name
Title
Email
Social Networks
avatar
Jonah Bookman Vice President of Digital Growth
Vice President of Digital Growth
j•••@•••
LinkedIn
avatar
Francesco Starace Partner
Partner
f•••@•••
LinkedIn
Upgrade to see contacts
avatar
kjLhJMXc1HWez3fF kjLhJMXc1HWez3fF
kjLhJMXc1HWez3fF
[email protected]
linkedin twitter
avatar
kjLhJMXc1HWez3fF kjLhJMXc1HWez3fF
kjLhJMXc1HWez3fF
[email protected]
linkedin twitter
avatar
kjLhJMXc1HWez3fF kjLhJMXc1HWez3fF
kjLhJMXc1HWez3fF
[email protected]
linkedin twitter
Investment-team contacts for EQT Life Sciences (LSP) — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about EQT Life Sciences (LSP)

EQT Life Sciences (LSP) is a venture capital and private equity firm. It backs companies at Late Stage (Series C+), Series B, Seed, Pre-seed and Series A, writing tickets of $10-50 m.
EQT Life Sciences (LSP) is located in Amsterdam, North Holland, Netherlands.
EQT Life Sciences (LSP) was founded in 1987.
EQT Life Sciences (LSP) invests in companies and startups in Life Sciences, MedTech, Medical Devices, Digital, Biotechnology, HealthTech, CleanTech, Energy, Software, SaaS, Robotics, Healthcare Services, Foodtech, Food and Beverage, Industrial, Technology, Other.
EQT Life Sciences (LSP) invests in companies and startups in Europe, North America.
EQT Life Sciences (LSP) invests in companies and startups at Late Stage (Series C+), Series B, Seed, Pre-seed, Series A.
EQT Life Sciences (LSP) usually invests $10-50 m on average.
EQT Life Sciences (LSP) has around $2 690 000m assets under management.
EQT Life Sciences (LSP) last fund was created/launched in 2023-03-12
EQT Life Sciences (LSP) can be reached through its website lspvc.com/index.html, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for EQT Life Sciences (LSP) — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query EQT Life Sciences (LSP) directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 26 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.